Latest1 information on COVID-19

Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial

Not Recruiting

Trial ID: NCT00185900

Age - 18 Years-N/A Condition - Obstetrics, Maternal and Fetal Medicine, Neonatal and Developmental Medicine Gender - Female Accepting Healthy Volunteers - No

Purpose

To compare intravenous magnesium sulfate to oral nifedipine for acute tocolysis of preterm labor

Official Title

Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial

Stanford Investigator(s)

Yasser El-Sayed, Professor
Yasser El-Sayed, Professor

Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery

Eligibility


Inclusion Criteria::- Uterine contractions and cervical change or ruptured membranes in a
preterm gestation Exclusion Criteria:- placental abruption, fetal distress, placenta
previa, maternal medical contraindication to tocolysis

View More
View Less

Intervention(s):

drug: Magnesium Sulfate

drug: Nifedipine

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Yasser El-Sayed
6507233198

©2022 Stanford Medicine